175 related articles for article (PubMed ID: 26872227)
1. Factors associated with treatment for latent tuberculosis in persons living with HIV/AIDS.
Aquino DS; Moura LC; Maruza M; Silva AP; Ximenes RA; Lacerda HR; Miranda Filho Dde B; Albuquerque Mde F
Cad Saude Publica; 2015 Dec; 31(12):2505-13. PubMed ID: 26872227
[TBL] [Abstract][Full Text] [Related]
2. Treatment guidelines for latent tuberculosis infection.
;
Kekkaku; 2014 Jan; 89(1):21-37. PubMed ID: 24654427
[TBL] [Abstract][Full Text] [Related]
3. Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study.
Pipitò L; Ricci ED; Maggi P; De Socio GV; Pellicano GF; Trizzino M; Rubino R; Lanzi A; Crupi L; Capriglione I; Squillace N; Nunnari G; Di Biagio A; Bonfanti P; Cascio A;
Viruses; 2024 May; 16(5):. PubMed ID: 38793658
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of isoniazid salvage therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders - A retrospective cohort study in Taiwan.
Huang SF; Chen MH; Wang FD; Tsai CY; Fung CP; Su WJ
J Microbiol Immunol Infect; 2018 Dec; 51(6):784-793. PubMed ID: 28739436
[TBL] [Abstract][Full Text] [Related]
5. Acceptability of treatment of latent tuberculosis infection in newly HIV-infected young women in Uganda.
Bark CM; Morrison CS; Salata RA; Byamugisha JK; Katalemwa NH; Mugerwa RD; Mukasa JB; Musoke RN; Nankya-Mutyoba J; Rwambuya S; Walker CJ; Johnson JL
Int J Tuberc Lung Dis; 2010 Dec; 14(12):1647-9. PubMed ID: 21144254
[TBL] [Abstract][Full Text] [Related]
6. Updates on the risk factors for latent tuberculosis reactivation and their managements.
Ai JW; Ruan QL; Liu QH; Zhang WH
Emerg Microbes Infect; 2016 Feb; 5(2):e10. PubMed ID: 26839146
[TBL] [Abstract][Full Text] [Related]
7. [Latent tuberculosis infection in persons with HIV/AIDS, associated factors, and progression to active disease in a city in southern Brazil].
Santos DTD; Garcia MC; Costa AANFD; Pieri FM; Meier DAP; Albanese SPR; Arcêncio RA; Dessunti EM
Cad Saude Publica; 2017 Aug; 33(8):e00050916. PubMed ID: 28832776
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of latent tuberculosis infection in patients undergoing treatment with immunobiologic agents: a four-year experience in an endemic area.
Lopes DMA; Pinheiro VGF; Monteiro HSA
J Bras Pneumol; 2019; 45(6):e20180225. PubMed ID: 31618298
[TBL] [Abstract][Full Text] [Related]
9. Incidence of tuberculosis in HIV-infected patients in Spain: the impact of treatment for LTBI.
Martínez-Pino I; Sambeat MA; Lacalle-Remigio JR; Domingo P;
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1545-51. PubMed ID: 24200266
[TBL] [Abstract][Full Text] [Related]
10. Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study.
Rubinowicz A; Bartlett G; MacGibbon B; Greenaway C; Ronald L; Munoz M; Menzies D
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1449-54. PubMed ID: 25517810
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
12. [Compliance with latent tuberculosis treatment: a public health challenge].
Bishara H; Ore L; Ravell DW
Harefuah; 2014; 153(3-4):167-70, 239, 238. PubMed ID: 24791558
[TBL] [Abstract][Full Text] [Related]
13. Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada.
Colson PW; Hirsch-Moverman Y; Bethel J; Vempaty P; Salcedo K; Wall K; Miranda W; Collins S; Horsburgh CR;
Int J Tuberc Lung Dis; 2013 Apr; 17(4):473-9. PubMed ID: 23485381
[TBL] [Abstract][Full Text] [Related]
14. Active tuberculosis risk with tumor necrosis factor inhibitors after treating latent tuberculosis.
Kwon M; Sung M; Kwon YJ; Song YG; Lee SW; Park MC; Park YB; Lee SK; Song JJ
J Clin Rheumatol; 2014 Mar; 20(2):68-73. PubMed ID: 24561408
[TBL] [Abstract][Full Text] [Related]
15. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City.
Li J; Munsiff SS; Tarantino T; Dorsinville M
Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705
[TBL] [Abstract][Full Text] [Related]
16. Active tuberculosis and Mycobacterium tuberculosis latent infection in patients with HIV/AIDS.
Gutierrez EB; Gomes V; Picone CM; Suga H; Atomiya AN
HIV Med; 2009 Oct; 10(9):564-72. PubMed ID: 19785665
[TBL] [Abstract][Full Text] [Related]
17. Intention of physicians to implement guidelines for screening and treatment of latent tuberculosis infection in HIV-infected patients in The Netherlands: a mixed-method design.
Evenblij K; Verbon A; van Leth F
BMC Public Health; 2016 Sep; 16(1):915. PubMed ID: 27585867
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Latent Tuberculosis Infection Treatment Failure Among Patients With Commercial Health Insurance-United States, 2005-2016.
Iqbal SA; Isenhour CJ; Mazurek G; Langer AJ; Chang MH; Truman BI
J Public Health Manag Pract; 2021 Jul-Aug 01; 27(4):E151-E161. PubMed ID: 31688742
[TBL] [Abstract][Full Text] [Related]
19. Advances in diagnosis and treatment of latent tuberculosis infection.
Chapman HJ; Lauzardo M
J Am Board Fam Med; 2014; 27(5):704-12. PubMed ID: 25201941
[TBL] [Abstract][Full Text] [Related]
20. Screening and treatment of latent tuberculosis infection among HIV-infected patients in resource-rich settings.
Lin AW; Lau SK; Woo PC
Expert Rev Anti Infect Ther; 2016; 14(5):489-500. PubMed ID: 26999724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
